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Body weight, weight changes and BMI are easily obtainable indicators of nutritional status, but
they do not provide information on the amount of fat-free and fat masses. The purpose of the
present study was to determine if fat-free mass (FFM) and fat mass were depleted in patients with
normal BMI or serum albumin at hospital admission. A group of 995 consecutive patients were
evaluated for malnutrition by BMI, serum albumin, and 50 kHz bioelectrical impedance analysis
and compared with 995 healthy adults, matched for age and height, and then compared with FFM
and fat mass percentiles previously determined in 5225 healthy adults. A BMI of #20 kg/m2 was
noted in 17:3 % of patients and serum albumin of #35 g/l was found in 14:9 % of patients. In
contrast, 31 % of all patients were below the tenth percentile for FFM, compared with 10:1 % of
controls (x2, P  0:0001; while 73 % of patients with BMI #20 kg/m2 and 31 % of patients with
BMI 20–24:9 kg/m2 fell below the tenth percentile for FFM. Furthermore, the FFM was lower in
patients than controls and the differences with age in FFM (lower) and fat mass (higher) were
greater in patients than in controls. BMI and albumin significantly underestimated the prevalence
of malnutrition in patients at hospital admission compared with body composition measurements.
Optimal nutritional assessment should therefore include objective measurement of FFM and fat
mass.
Malnutrition: Bioelectrical impedance analysis: Fat-free mass: Fat mass: Albumin
Protein–energy malnutrition is a dynamic process as a
result of an imbalance between energy (and protein) intake
and expenditure and leads to low body fat-free mass (FFM)
and fat mass. Malnutrition is common in the hospital setting.
In the United States, 40 to 50 % of hospitalized patients are
at risk of malnutrition (Bistrian et al. 1976) and up to 12 %
are severely malnourished (Detsky et al. 1987). The
situation is even worse in nursing home residents (Peter D
Hart Research Associates Inc., 1993). Similar projections
are also made for hospitals outside the United States (Bruun
et al. 1999; Edington et al. 2000). Malnutrition tends to
worsen during hospitalization (McWhirter & Pennington,
1994).
Malnutrition-related complications increase hospital care
costs (Martyn et al. 1998). Therefore routine nutritional
screening of patients for malnutrition at hospital admission
can be cost-saving (Reilly et al. 1988; Sheils et al. 1999).
Although no gold standard has been established, a number
of nutrition screening and assessment tools are available that
can be incorporated into routine care. Nutritional screening
differentiates individuals who are at moderate or high risk of
nutritional problems from those who are in good nutritional
status. Significant weight loss over time, low weight or
BMI, reduction in mid-arm circumference and skinfold
measurements, changes in functional status, low serum
albumin and reduced food intake are associated with poor
nutritional status in adults. Furthermore, loss of FFM is a
marker of malnutrition, because it is a consequence of
negative imbalance between energy (and protein) needs and
intake that occurs for more than a few days, when early
markers are probably more functional parameters (e.g.
muscle dysfunction).
Although body weight, weight changes (Reynolds et al.
1999) and BMI (Curtin et al. 1997) are easily obtainable,
they do not provide information on the distribution of FFM
and fat mass. BMI was shown to be inaccurate in assigning a
fatness risk factor to individuals, especially among women
(Morabia et al. 1999). Skeletal muscle atrophy is prevalent
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in sick (Bruera, 1992) and elderly populations (Baumgartner
et al. 1998) and is strongly associated with disability and
morbidity (Dempsey et al. 1988). It is associated with
depletion of FFM but normal body weight and has been
documented in many pathologies, such as cancer (Costelli &
Baccino, 2000), AIDS (Von Roenn et al. 1994), cardiac
cachexia (Paccagnella et al. 1994), and chronic obstructive
pulmonary disease (Engelen et al. 1994). Therefore,
assessment of body compartments may substantially
improve the assessment of malnutrition.
Bioelectrical impedance analysis (BIA) has been widely
used for the simultaneous measuring of FFM and fat mass. It
is an easy, safe and non-invasive bedside technique (Kyle &
Pichard, 2000). BIA is valid for the estimation of FFM and
fat mass, provided that an equation appropriate for the
population is used. The BIA equation used in the present
study was validated in healthy subjects (Kyle et al. 2001a),
stable in- and outpatients (Kyle et al. 2001b), and elderly
subjects (Genton et al. 2001). Percentile tables of FFM and
fat mass, previously established in 5225 healthy adults
(Kyle et al. 2001c) permit the evaluation of low FFM in
patients.
The purpose of the present controlled population study
was to determine if BIA-derived FFM and fat mass were
depleted in patients with normal BMI or serum albumin and
if FFM and fat mass differed in patients at hospital
admission from healthy controls.
Subjects and methods
Patients
All adult patients admitted to the emergency centre for
medical or surgical reasons and subsequently hospitalized
were eligible for inclusion. Every 10th patient who met
entry criteria was included in the study during a 3 month
period. The study included 995 patients; two patients
refused to participate in the study. Thirty-five patients with
oedema, burns or treated with peritoneal- or haemodialysis
and twenty-six patients with rehydration perfusion and
major cardio-respiratory resuscitation were excluded. All
patients were measured in the emergency room within 3 h
after admission, by the same two co-workers of the
Nutrition Unit. Patients were categorized as medical,
surgical or trauma, depending on the service in which
they hospitalized after admission.
Informed consent was obtained from all subjects. The
study protocol complied with the requirements of the
Geneva University Hospital Ethics Rules.
Controls
Healthy adults (525 men and 470 women), matched for age
(^2 years) and height (^2 cm) of patients, were selected
from our database. Our database consists of 5225 healthy
adults between the ages of 15 and 98 years, who were non-
randomly recruited in the greater Geneva area and represent
the same population as the patients (Kyle et al. 2001c). This
database was the source for FFM percentiles previously
established (Kyle et al. 2001c). BMI, resistance, reactance,
FFM, fat mass and percentage fat mass (adjusted for age and
height) did not differ significantly (P.0:5) between study-
matched control subjects and the entire control population.
Measurements
Anthropometric measurements and bioelectrical impedance
analysis. All measurements were performed during the
hospital admission examination. Body height was measured
to the nearest 0:5 cm and body weight to the nearest 0:1 kg
on a chair scale or a hoist with attached weighing device for
patients who were bed-ridden. The scales were cross-
calibrated weekly. Subjects were in indoor clothing without
shoes and heavy sweaters or jackets. Percentage ideal body
weight was derived from the Metropolitan Life Insurance
Company (1983) tables. Values used were the midpoints for
medium frame for each height.
The FFM and fat masses were assessed by BIA as
previously described by Lukaski (1986). Whole-body
resistance (R) and reactance was measured with four
surface electrodes placed on the right wrist and ankle.
Briefly, an electrical current of 50 kHz and 0:8 mA was
produced by a generator (RJL-101w analyzers, RJL
Systems Inc, Clinton Twp, MI) and applied to the skin by
the use of adhesive electrodes (3M Red Dot T, 3M Health
Care, Borken, Germany) with the subject lying supine
(Houtkooper et al. 1996). The skin was cleaned with
ethanol–water (70:30, v/v). The RJL-101w generator (RJL
Systems Inc, Clinton Twp, MI) was cross-validated at
50 kHz against the Xitronw analyzer (Xitron Technologies,
Inc, San Diego, CA). The limit of tolerance between
instruments was ^5V at 50 kHz using a calibration jig and
in vivo measurements.
FFM was calculated by the following multiple regression
equation that had been previously validated against dual-
energy X-ray absorptiometry (Hologic QDR-4500, Hologic
Inc., Waltham, MA) in 343 healthy subjects between 18 and
94 years of age (Kyle et al. 2001a):
FFM  2 4:104 1 0:518  height2=resistance
1 0:231  weight1 0:130  reactance
1 4:229  sex men  1; women  0:
DXA–measured FFM was 54:0 ^ 10:7 kg: BIA-pre-
dicted FFM was 54:0 ^ 10:5 kg; r 0:986, standard error of
the estimate (SEE) 1:72 kg, technical error (TE) 1:74 kg.
This BIA equation had further been tested in elderly
subjects (Genton et al. 2001) and pre- and post-transplant
patients (Kyle et al. 2001b) and found to be valid in elderly
and diseased patients.
A standardized protocol was used for all our body
composition studies. Therefore the methods used did not
differ between the database of reference subjects and
subjects included in the present study. Patients were
assigned an age-appropriate percentile rank for FFM based
upon our percentile tables of healthy Swiss subjects (n 5255
subjects between the ages of 15 and 98 years) (Kyle et al.
2001c). Percentile rank below the 5th percentile (P#5) and
10th percentile (P#10) were used to define FFM depletion.
Albumin. Blood samples were routinely drawn at the
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same time as the samples necessary for diagnosis and
treatment, before initiation of intravenous fluids. Albumin
was measured by immunonephelometry (Fink et al. 1989).
The normal range of our biochemistry laboratory for
albumin was 35–55 g/l.
Statistical analysis
StatView statistical software package version 4.1 (Abacus
Concepts, Berkeley, CA) was used for statistical analysis.
The results are expressed as mean and standard deviation.
The differences between age groups were analysed by
ANOVA. Unpaired t tests were used to compare patients
and controls. Chi-square tests were used to compare the
differences between malnutrition indicators. Statistical
significance was set at P#0:05 for all tests.
Results
The anthropometric characteristics of the controls and
emergency centre men and women are shown in Table 1.
Height was lower in older than younger male and female
controls and patients, but did not differ significantly
between controls and patients. Weight was higher in older
patients and controls than younger subjects, and was lower
in 75–100-year-old patients compared with 55–74-year-old
controls.
Resistance was significantly higher in patients than
controls and increased with age (data not shown). Higher
resistance and lower reactance measured in patients than in
controls and in older v. younger subjects translate into lower
FFM (Table 2) found in patients than in controls and in older
v. younger subjects.
Nutrition assessment parameters
Low serum albumin (albumin #35 g/l) (Table 3) was found
in 14:9 % of patients. Low correlations were found between
albumin and FFM (r 0:216, P,0:001, data not shown). A
BMI of #20 kg/m2 was noted in 17:3 % of patients compared
with 8:5 % of controls (Table 3). Of the patients, 31 % were
below P#10 for FFM, compared with 10:1 % of controls (x2,
P#0:0001). Medical and surgical patients (35:5 and 30:5 %,
respectively) had higher incidence of low FFM than trauma
patients (P#0:0001) who did not differ from controls.
Further analysis (Table 4) showed that 72:9 % of patients
with a BMI #20 kg/m2 fell below P#10, compared with
32:9 % of controls. Furthermore, 31:2 % of patients with a
BMI of 20–24:9 kg/m2, compared with 12:0 % of healthy
controls, and 13:1 % of patients with a BMI 25–29:9 kg/m2
compared with 2:7 % of controls fell below the FFM P#10.
These results show that a low FFM is noted in a higher
proportion of patients than controls and is found in almost
one third of patients with a ‘normal’ BMI of 20–24:9 kg/m2.
Thus BMI was not sensitive to evaluate FFM depletion.
Body composition measurements by BIA are more sensitive
to identify patients who are FFM-depleted than is BMI.
Fat-free and fat body mass
There were minimal differences in BMI between patients
and controls (Table 2). FFM remained stable until 54 years
Table 1. Anthropometric and bioelectrical impedance characteristics of healthy male and female controls and patients
(Mean values and standard deviations)
Age (years) … All (15–95) 15–34 35–54 55–74 .75
Mean SD Mean SD Mean SD Mean SD Mean SD
Men
n 525 153 165 135 72
Height (cm)
controls 173:2 7:6 175:9 7:4 174:0* 7:1 171:9* 6:8 168:4** 7:5
patients 172:6 8:0 175:1 7:7 173:2* 7:2 171:5 8:4 168:2* 7:2
Weight (kg)
controls 74:5 10:2 73:1 10:2 76:6* 10:1 75:4 10:1 71:3* 9:0
patients 72:5† 12:9 70:5† 12:3 73:2† 12:9 74:9 13:4 70:1* 12:1
IBW (%)
controls 107:6 12:3 103:4 10:8 109:7** 11:9 110:1 12:9 107:0 13:1
patients 105:1† 16:7 100:2† 14:9 105:9*† 17:0 109:5 17:5 105:1 16:1
Women
n 470 113 114 96 147
Height (cm)
controls 160:4 7:3 164:9 6:9 162:3** 6:2 159:6* 5:9 156:1** 6:7
patients 160:3 7:3 164:4 7:1 162:3* 6:2 159:6* 5:9 156:0** 6:8
Weight (kg)
controls 60:7 9:6 58:3 6:2 59:3 8:1 64:2** 11:8 61:4* 10:5
patients 60:1 12:3 57:9 9:6 64:3**†† 11:3 62:3 15:2 57:2**† 11:5
IBW (%)
controls 103:8 16:1 95:7 8:5 99:5 11:6 110:2** 18:7 109:1 18:1
patients 102:7 19:8 95:3 14:1 107:8**†† 18:4 107:3 25:5 101:5*†† 18:5
IBW, ideal body weight (Metropolitan Life Insurance Company, 1983).
ANOVA comparison between age groups within a row: *P,0:05, **P,0:001.
Mean values were significantly different from those of the control group: †P,0:05, ††P,0:001 (unpaired t test).
Nutritional assessment of hospital patients 727
https://doi.org/10.1079/BJN2001470
Downloaded from https:/www.cambridge.org/core. University of Basel Library, on 30 May 2017 at 16:41:02, subject to the Cambridge Core terms of use, available at https:/www.cambridge.org/core/terms.
of age in male controls and 74 years of age in female
controls, while FFM decreased in patients with age after 54
years. The male and female patients $75 years of age had
about 16–17 % lower FFM than the youngest control men
and women compared with 12 and 8:5 % lower FFM noted
in $75 year-old male and female controls, respectively.
Thus the decrease with age in FFM in patients was greater
than the age-related decrease in the controls. The patients
classified as FFM P,10 had 20 % lower FFM than controls
(data not shown). Patients $75 years old classified as P,10,
had 29 % lower FFM than the youngest controls and 19 and
23 % lower FFM than age-matched healthy control men and
women, respectively. Thus FFM depletion is significant in
patients at hospital admission.
The peak fat mass in 55–74-year-old male and female
patients was about 55 and 48 % higher, respectively, than in
the youngest control men and women (aged 15–34 years of
age), compared with 40 and 34 % higher fat mass in control
men and women, respectively.
These results show that FFM was lower in patients than
controls and the differences with age in FFM (lower) and fat
mass (higher) were greater in patients than in controls. Thus
the higher fat mass observed in the older subjects obscures
FFM depletion when BMI is used as a nutritional indicator,
since there were insignificant differences in BMI between
patients and controls.
Discussion
The purpose of a nutritional assessment is to identify
patients with depleted body tissues and increased risks for
complications. This is the first study that evaluates
differences in FFM and fat mass of a large number of
patients at hospital admission compared with healthy
controls and shows patients had lower FFM and higher fat
mass than controls. The prevalence of low FFM was much
higher than was determined by low BMI and albumin.
Prevalence of nutritional risk
The higher prevalence of nutritional risk by definition of
FFM P,10 suggests that BMI and serum albumin
underestimated the prevalence of malnutrition at hospital
admission (Table 3).
A low prevalence of malnutrition by criteria of BMI
#20 kg/m2 was found in Dublin in general surgical patients
and surgical oncology patients (6–7 %) and skinfold
measurements #15th percentile (Corish, 1999). Corish
et al. (1999) expected a higher prevalence of malnutrition in
their patients undergoing major surgery and found 37 % had
indeed lost $10 % of body weight. This suggests that BMI
does not identify patients at nutritional risk. It is possible
that recent increases in weight and BMI invalidate
anthropometric reference standards to define nutritional
status in the USA and Western Europe, because they do not
identify body compartments, i.e. FFM and fat mass.
BMI and nutritional risk
The lower prevalence of nutritional risk noted in patients by
a BMI of #20 kg/m2 than FFM P,10 (Table 3) suggests
that BMI did not identify the subjects who were FFM-
depleted in our study. We also found that patients with a
normal BMI at the same time had below normal FFM.
Furthermore, the incidence of a low FFM was common in
patients with a BMI in the normal range (20–25 kg/m2) and
is noted in some overweight patients (BMI 25–29:9 kg/m2).
The relationship between BMI and protein–energy
Table 2. Body composition differences between age groups, and between controls and patients*
Age (years) … All (15–95) 15–34 35–54 55–74 .75
Mean SD Mean SD Mean SD Mean SD Mean SD
Men
BMI (kg/m2)
controls 24:8 2:9 23:6 2:4 25:3†† 2:7 25:5 3:0 25:2 3:3
patients 24:1‡ 3:9 23:0‡ 3:4 24:4†‡ 3:9 25:4† 4:0 24:7 3:7
Fat-free mass (kg)
controls 58:5 6:5 59:8 6:3 60:5 6:1 57:5†† 5:6 52:6†† 5:4
patients 54:9‡‡ 7:6 56:6‡‡ 7:1 56:0‡‡ 7:2 54:3†‡‡ 8:0 50:1†‡ 6:6
Fat mass (kg)
controls 16:1 5:8 13:3 5:2 16:1†† 5:4 17:8† 5:7 18:7 5:4
patients 17:5‡‡ 7:4 14:0 6:5 17:3†† 7:3 20:6††‡‡ 7:0 20:0 7:1
Women
BMI (kg/m2)
controls 23:7 3:9 21:5 2:0 22:5† 2:6 25:2†† 4:3 25:3 4:3
patients 23:4 4:5 21:4 3:2 24:4††‡‡ 4:2 24:5 5:8 23:5‡ 4:3
Fat-free mass (kg)
controls 41:1 4:9 42:4 3:8 42:2 4:1 42:0 5:3 38:8†† 5:0
patients 38:7‡‡ 6:0 40:2‡‡ 4:8 41:9† 4:9 38:7††‡‡ 6:1 35:2 5:7
Fat mass (kg)
controls 19:6 6:9 15:9 3:8 17:1 5:2 22:2†† 7:7 22:6 7:3
patients 21:4‡‡ 7:9 17:7‡ 6:1 22:4††‡‡ 7:5 23:6 10:0 22:1 7:1
* For details of subjects and procedures, see Table 1 and p. 726.
Comparison by ANOVA between adjacent age groups: †P,0:05, ††P,0:001.
Mean values were significantly different from those of the control group: ‡P,0:05, ‡‡P,0:001 (unpaired t test).
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malnutrition remains debated. Galanos et al. (1997) found
that BMI was an independent predictor of excess mortality
within 180 d. An increased risk for mortality was noted in
patients with low BMI (values P#15). The authors
speculated that the lack of a protective ‘nutritional reserve’
during serious illness might have worsened outcome in
patients with low BMI. Ham (Ham, 1992) suggested that the
optimal range for BMI is higher, i.e. 24–29 kg/m2, for
healthy elderly people. Schols et al. (1998) found an inverse
relationship between BMI and survival in chronic
obstructive pulmonary disease patients. They identified a
BMI of #25 kg/m2 as the threshold value below which the
mortality risk was clearly increased.
Higher mortality rates reported in hospital patients with
normal BMI might be due to unrecognized depletion of
FFM. The low FFM noted in our subjects at hospital
admission, including patients in the normal BMI range,
might explain the increased nutritional risk and risk of
illness. Potter et al. (1988) found lowest mortality in
hospitalized patients occurred at moderate overweight, and
the higher mortality in thin patients could not be explained
by weight loss between hospitalizations. We hypothesize
that weight loss in combination with already low FFM
reserves could explain higher mortality in thin subjects, and
moderate overweight would decrease the likelihood of low
FFM, thus decreasing mortality in overweight subjects.
Rajala et al. (1990) found that a weight loss over the first 24
months of follow-up resulted in five times the risk of
mortality at 40 months. Reynolds et al. (1999) found that
having a low BMI (#23 kg/m2) and weight loss of more
than 4:5 kg in 1 year were both associated with increased risk
of mortality over a 6 year period in community-dwelling
women aged $65 years. It is therefore quite possible that
weight loss, which results in loss of both FFM and fat
mass, in combination with pre-existing FFM depletion in
patients with low and moderate BMI could explain the
increased risk for mortality in patients.
Body composition parameters
These results show that FFM was lower in patients than
controls and the differences with age in FFM (lower) and fat
mass (higher) were greater in patients than in controls.
(Table 2). Patients classified as FFM P,10 had 20 % lower
FFM than controls. This difference was even greater in
patients aged $75 years. Furthermore, low FFM (P,10) is
found in almost one third of patients admitted to hospital.
Our study confirms that FFM depletion and malnutrition
is common in patients at hospital admission (Bistrian et al.
1976; Bruun et al. 1999; Edington et al. 2000). Higher
mortality has been noted in patients with low muscle mass.
Kotler et al. (1989) found that death occurred at 54 % of
normal for body cell mass while it occurred at 66 % of ideal
weight in AIDS patients (Kotler et al. 1989). Covinsky et al.
(1999) found severely malnourished patients were at high
risk for mortality during the first year after hospitalization
and the risk remained elevated after adjustment for acute
illness, severity, chronic co-morbidity and functional status
at admission. They suggested that malnutrition might
accelerate the fatal outcome of chronic diseases rather than
simply act as a marker for pre-terminal status. Their analysis
further suggested that malnourished patients are at risk for
delayed recovery and/or accelerated functional decline
following hospitalization. Volkert et al. (1992) demon-
strated that the relationship between clinical nutritional
assessment and outcomes was independent of other
prognostic markers and was valid for patient outcomes
other than mortality. We suggest that the low FFM is an
important factor in patient outcome.
We are unable to confirm mortality rates in our patients.
However the FFM depletion reported in one third of patients
admitted to hospital in the present study confirms that
nutritional risk is significant at hospital admission and is
frequently unrecognized because body compartments are
not routinely assessed at hospital admission. Both serum
Table 3. Prevalence of malnutrition by various nutritional parameters and diagnostic categories at hospital admission*
Controls All patients
Medical
patients
Surgical
patients
Trauma
patients
Difference
between group
values (x2 test)
n % n % n % n % n % df P
Serum albumin†
.35 g/l N/A 556 85:1 387 83:0 138 89:6 31 93:9 2 0:048
#35 g/l N/A 97 14:9 79 17:0 16 10:4 2 6:1
BMI (kg/m2)
.30 66 6:6 85 8:5 51 8:3 23 9:1 11 8:9 9 0:0001
25:0–29:9 307 30:9 252 25:3 155 25:1 67 26:5 30 24:2
20:0–24:9 536 53:9 486 48:8 306 49:5 111 43:8 69 55:6
#20 86 8:6 172 17:3 106 17:2 52 20:6 14 11:3
Fat-free mass‡
P.25 743 74:7 515 51:8 292 47:2 132 52:2 91 73:4 9 0:0001
P10–25 153 15:4 169 17:0 107 17:3 44 17:4 18 14:5
P5–10 49 4:9 89 8:9 56 9:1 28 11:1 5 4:0
P,5 50 5:0 222 22:3 163 26:4 49 19:4 10 8:1
N/A, not applicable; P, percentile.
* For details of subjects and procedures, see Table 1 and p. 726.
† n 653.
‡ Fat-free mass percentiles determined from age- and gender-appropriate reference tables (see pp. 727–728).
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albumin and BMI underestimated nutritional risk at hospital
admission in the present study. This may be due to a lack of
recognition of FFM depletion, in part due to higher fat mass
noted in patients compared with controls. Therefore, body
composition measurements, such as BIA, could improve
nutritional assessment by assessing FFM and thus identify-
ing those patients who are at risk due to already depleted
FFM at hospital admission.
Limitations of study
We have no information on why patients were malnourished
and therefore could not distinguish between malnourished
secondary to inadequate intake and/or increased needs or
losses. The cause of malnutrition as well as the relationship
between malnutrition and patient outcome remains
unknown, but this is not relevant for the purpose of the
present study, which was to show that malnutrition is better
perceived by BIA-derived FFM than by BMI.
The BIA methods used may be criticized, but have been
optimized for the present study, namely: water and
electrolyte abnormalities are known to influence body
composition measurements, including BIA measurements.
To limit the impact of such an interference, BIA
measurements were performed before intravenous fluids
for medications and treatment for dehydration were
started, and care was taken to exclude patients with
oedema, dehydration, dialysis, burns and major cardio-
respiratory resuscitation (see p. 726). Mild non-visible
hydration abnormalities (overhydration) might have been
present in some patients. This would have resulted in the
overestimation of FFM and underestimation of the
prevalence of malnutrition.
BIA was validated against dual-energy X-ray absorptio-
metry. Dual-energy X-ray absorptiometry is not yet
universally recognized as a body composition reference
method because of methodological problems (e.g. recog-
nition of abnormal hydration) and systematic differences
between manufacturers. This does not, however, invalidate
the study, because trends in FFM and fat mass would not be
affected by systematic errors (e.g. over- or underestimation
of FFM would be the same in all subjects).
It is not known to what extent acute phase protein
responses might have affected the serum albumin levels
reported in the present study.
Conclusion
The degree of malnutrition was significantly underestimated
by BMI and serum albumin in patients admitted to the
hospital, compared with BIA-derived FFM. The FFM was
lower in patients than controls and the differences with age in
FFM (lower) and fat mass (higher) were greater in patients
than in controls. Thus body composition measurements
identified patients with low FFM and low or high fat mass
reserves. Optimal nutritional assessment should therefore
include objective measurement of FFM and fat mass.
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* For details of subjects and procedures, see Table 1 and p. 726.
† Fat-free mass percentiles determined from age- and gender-appropriate reference tables (see pp. 727–728).
‡ Total n for row, 100.
§ Total n for column, 100.
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